To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers

NCT03004404 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Placebo
DRUG: BI 730357
DRUG: BI 730357

Sponsor

Boehringer Ingelheim